Location History:
- San Francisco, CA (US) (1993)
- Melbourne, FL (US) (2000)
- San Mateo, CA (US) (2011 - 2013)
- Elizabeth, NJ (US) (2018)
- Auburn, CA (US) (2018 - 2021)
Company Filing History:
3 out of 3 
1 out of 2 
5 out of 832,880 Years Active: 1993-2021
Title: Claude Geoffrey Davis: Innovator in Engineered Cells
Introduction
Claude Geoffrey Davis is a notable inventor based in Auburn, CA (US), recognized for his contributions to the field of engineered cells. With a total of 9 patents, Davis has made significant strides in biotechnology, particularly in the development of specialized cells for medical applications.
Latest Patents
Davis's latest patents include innovative work on engineered endothelial cells expressing an ETS transcription factor. This invention relates to methods of creating and utilizing engineered endothelial cells, such as E40RF1+ ETV2+ cells, for co-culture applications. Another significant patent involves neural cells expressing adenovirus E4ORF1, which provides engineered neural cells, neural stem cells, or neural progenitor cells containing a nucleotide sequence that encodes an adenovirus E40RF1 polypeptide. This invention also outlines methods for making and using these engineered cells.
Career Highlights
Throughout his career, Davis has worked with various companies, including Angelica Therapeutics, Inc. His work has focused on advancing the understanding and application of engineered cells in therapeutic settings.
Collaborations
Davis has collaborated with notable individuals in his field, including Deepshikha Datta and Matthew Paul Baker. These collaborations have contributed to the development of his innovative patents and research.
Conclusion
Claude Geoffrey Davis stands out as a prominent inventor in the realm of engineered cells, with a strong portfolio of patents that reflect his dedication to advancing biotechnology. His work continues to influence the field and pave the way for future innovations.